Indium In 111 Capromab Pendetide

CHEMBL2108800 Phase 4 Zugelassen Antibody
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

A radioactive imaging agent used in nuclear medicine scans to detect prostate cancer that has spread to lymph nodes or other tissues. It targets a protein found on prostate cancer cells.

Therapeutische Bereiche

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A radioactive imaging agent used in nuclear medicine scans to detect prostate cancer that has spread to lymph nodes or other tissues. It targets a protein found on prostate cancer cells.

Yes, Indium In 111 Capromab Pendetide is an approved drug. It has reached clinical phase 4. It is classified as a Antibody.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108800. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.